These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 9751497

  • 1. Systemic challenge with endotoxin stimulates corticotropin-releasing hormone and arginine vasopressin secretion into hypophyseal portal blood: coincidence with gonadotropin-releasing hormone suppression.
    Battaglia DF, Brown ME, Krasa HB, Thrun LA, Viguié C, Karsch FJ.
    Endocrinology; 1998 Oct; 139(10):4175-81. PubMed ID: 9751497
    [Abstract] [Full Text] [Related]

  • 2. Endotoxin inhibits the reproductive neuroendocrine axis while stimulating adrenal steroids: a simultaneous view from hypophyseal portal and peripheral blood.
    Battaglia DF, Bowen JM, Krasa HB, Thrun LA, Viguié C, Karsch FJ.
    Endocrinology; 1997 Oct; 138(10):4273-81. PubMed ID: 9322940
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandins mediate the endotoxin-induced suppression of pulsatile gonadotropin-releasing hormone and luteinizing hormone secretion in the ewe.
    Harris TG, Battaglia DF, Brown ME, Brown MB, Carlson NE, Viguié C, Williams CY, Karsch FJ.
    Endocrinology; 2000 Mar; 141(3):1050-8. PubMed ID: 10698181
    [Abstract] [Full Text] [Related]

  • 4. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL, Irvine CH, Livesey JH, Donald RA.
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [Abstract] [Full Text] [Related]

  • 5. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D, Pham T, Fullerton MJ, Ooi G, Funder JW, Clarke IJ.
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [Abstract] [Full Text] [Related]

  • 6. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL, Irvine CH.
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [Abstract] [Full Text] [Related]

  • 7. Combined hypervolemia and hypoosmolality alter hypothalamic-pituitary-adrenal axis response to endotoxin stimulation.
    Dadoun F, Velut JG, Guillaume V, Sauze N, Orsoni JC, Gaillard RC, Oliver CC.
    Neuroendocrinology; 1999 May; 69(5):352-9. PubMed ID: 10343176
    [Abstract] [Full Text] [Related]

  • 8. Central administration of corticotrophin releasing hormone but not arginine vasopressin stimulates the secretion of luteinizing hormone in rams in the presence and absence of testosterone.
    Tilbrook AJ, Canny BJ, Stewart BJ, Serapiglia MD, Clarke IJ.
    J Endocrinol; 1999 Aug; 162(2):301-11. PubMed ID: 10425469
    [Abstract] [Full Text] [Related]

  • 9. Does cortisol mediate endotoxin-induced inhibition of pulsatile luteinizing hormone and gonadotropin-releasing hormone secretion?
    Debus N, Breen KM, Barrell GK, Billings HJ, Brown M, Young EA, Karsch FJ.
    Endocrinology; 2002 Oct; 143(10):3748-58. PubMed ID: 12239084
    [Abstract] [Full Text] [Related]

  • 10. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat.
    Makara GB, Sutton S, Otto S, Plotsky PM.
    Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631
    [Abstract] [Full Text] [Related]

  • 11. Effect of endotoxin on the hypothalamic-pituitary-adrenal axis in sheep.
    Dadoun F, Guillaume V, Sauze N, Farisse J, Velut JG, Orsoni JC, Gaillard R, Oliver C.
    Eur J Endocrinol; 1998 Feb; 138(2):193-7. PubMed ID: 9506866
    [Abstract] [Full Text] [Related]

  • 12. Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. I. Direct evidence for separate episodic and basal components of FSH secretion.
    Padmanabhan V, McFadden K, Mauger DT, Karsch FJ, Midgley AR.
    Endocrinology; 1997 Jan; 138(1):424-32. PubMed ID: 8977432
    [Abstract] [Full Text] [Related]

  • 13. The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey.
    Xiao E, Xia-Zhang L, Thornell D, Shalts E, Ferin M.
    Neuroendocrinology; 1996 Sep; 64(3):225-32. PubMed ID: 8875440
    [Abstract] [Full Text] [Related]

  • 14. Endotoxin inhibits pituitary responsiveness to gonadotropin-releasing hormone.
    Williams CY, Harris TG, Battaglia DF, Viguié C, Karsch FJ.
    Endocrinology; 2001 May; 142(5):1915-22. PubMed ID: 11316757
    [Abstract] [Full Text] [Related]

  • 15. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.
    Caraty A, Grino M, Locatelli A, Guillaume V, Boudouresque F, Conte-Devolx B, Oliver C.
    J Clin Invest; 1990 Jun; 85(6):1716-21. PubMed ID: 2161426
    [Abstract] [Full Text] [Related]

  • 16. Does cortisol inhibit pulsatile luteinizing hormone secretion at the hypothalamic or pituitary level?
    Breen KM, Karsch FJ.
    Endocrinology; 2004 Feb; 145(2):692-8. PubMed ID: 14576178
    [Abstract] [Full Text] [Related]

  • 17. Short-term secretion patterns of corticotropin-releasing hormone, arginine vasopressin and ACTH as shown by intensive sampling of pituitary venous blood from horses.
    Alexander SL, Irvine CH, Donald RA.
    Neuroendocrinology; 1994 Sep; 60(3):225-36. PubMed ID: 7969780
    [Abstract] [Full Text] [Related]

  • 18. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP, Clarke IJ, Funder JW, Engler D.
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [Abstract] [Full Text] [Related]

  • 19. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [Abstract] [Full Text] [Related]

  • 20. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
    Livesey JH, Donald RA, Irvine CH, Redekopp C, Alexander SL.
    Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.